“ID: 2036 Next-Generation Sequencing to Evaluate Frequency of BCR-ABL1 Kinase Domain Imatinib-Resistance Mutations”. Biomedical Research and Therapy, vol. 4, no. S, Sept. 2017, p. S67, https://doi.org/10.15419/bmrat.v4iS.275.